In the present study, we also found that genetically predicted higher OAS1 – an interferon-induced broad-spectrum antiviral enzyme – was associated with lower risk of both susceptibility and severity of COVID-19, consistent with findings of a recent published report (Zhou et al., 2021). This evidence concerns the gene OAS1 and COVID-19.